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Abstract  
Background: In the UK, treatment recommendations for patients with cancer are routinely made by 
multidisciplinary teams in weekly meetings. However, their performance is variable.  
Objective: To explore the underlying structure of multidisciplinary decision-making process, and 
examine how it relates to team ability to reach a decision.  
Design, Settings and Participants: A cross-sectional observational study consisting of 1,045 patient 
reviews across four multidisciplinary cancer teams from teaching and community hospitals in London, 
UK from 2010 to 2014. Meetings were chaired by surgeons.  
Measurements: We used a validated observational instrument (Metric for the Observation of Decision-
making in Cancer Multidisciplinary Meetings) consisting of 13 items to assess the decision-making 
process of each patient discussion. Rated on a five-point scale, the items measured quality of presented 
patient information, and contributions to review by individual disciplines. A dichotomous outcome 
(yes/no) measured team ability to reach a decision. Ratings were submitted to Exploratory Factor 
Analysis and regression analysis.  
Results: The exploratory factor analysis produced four factors, labelled ‘Holistic and Clinical inputs’ 
(patient views, psychosocial aspects, patient history, comorbidities, oncologists’, nurses’, and 
surgeons’ inputs), ‘Radiology’ (radiology results, radiologists’ inputs), ‘Pathology’ (pathology results, 
pathologists’ inputs), and ‘Meeting Management’ (meeting chairs’ and coordinators’ inputs). A 
negative cross-loading was observed from surgeons’ input on the fourth factor with a follow-up 
analysis showing negative correlation (r = -0.19, p < 0.001). In logistic regression, all four factors 
predicted team ability to reach a decision (p < 0.001).  
Limitations: Hawthorne effect is the main limitation of the study.  
Conclusions: The decision-making process in cancer meetings is driven by four underlying factors 
representing the complete patient profile and contributions to case review by all core disciplines. 
Evidence of dual-task interference was observed in relation to the meeting chairs’ input and their 
corresponding surgical input into case reviews.  
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Introduction 
Background 
As a mandatory part of cancer care services in the UK, multidisciplinary team meetings (MDM) 
comprise of diverse range of professionals – including surgeons, oncologists, radiologists, specialist 
cancer nurses and pathologists [1]. Their purpose is to provide expert reviews of patient cases and 
formulate treatment recommendations, thus improving patient experience and ensuring well-
coordinated delivery of safe, high quality care. Although cancer guidelines support a multidisciplinary 
approach [1], the empirical evidence of its effectiveness in terms of patient survival remains unclear 
[2], and team performance across tumors is variable [3]. One pattern that keeps re-emerging in recent 
studies is the skewed contribution to case reviews towards senior physicians and biomedical aspects of 
the disease; in contrast, cancer nurses’ input, patients’ comorbidities, and their psychosocial 
circumstances are underrepresented [4-6]. In line with this pattern, evidence from patient experience 
studies shows suboptimal experience of care often due to psychosocial circumstances not being 
adequately addressed and a ‘holistic’ view of the patient not being considered by the healthcare 
providers [7-8]. Moreover, multidisciplinary team (MDT) members highlighted the importance of 
having a complete patient profile, as well as all participating disciplines in attendance, for effective 
decision-making [9]. Improving MDT working therefore is complex although highly important with 
the cancer incidence and costs of care being predicted to rise [10-11], while the significant financial 
pressures on the healthcare remain [12].  
The National Cancer Action Team in England identified core domains essential for effective MDT 
working, including the team (e.g. attendance, team culture, training), infrastructure for meetings, 
organisation and logistics, team governance, and finally, clinical decision-making process [13] – the 
latter being the primary focus of this paper. Time pressures, cancer specialist non-attendance, lack of 
necessary information, poor consideration of patient wishes and comorbidities [9], as well as poor 
team climate [14] have all been reported to have negative impact on the team in MDMs. 
Correspondingly, the functional perspective of group decision-making posits that the internal factors 
coming from within the group  (member composition, group size, interactions, culture, beliefs, 
attitudes, history among group members), and the external circumstances (time pressure, workload) 
both impact the way groups perform, with the group size and diversity being positively related to 
performance and range of abilities, and negatively related to effective processes and equality of 
participation [15-16]. This pattern is also evident in cancer MDMs.  
More research is therefore needed to understand how the process of decision-making is currently 
structured in MDMs - whether this is at the service of promoting effective decision-making, and how 
it impacts team outcomes. For instance, evidence from MDMs shows that the chairing of the meeting 
tends to be led by one of the contributing disciplines, and predominantly by more senior surgical 
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members of the team [17]. This, however, may not be an optimal set up. Evidence from cognitive 
psychology shows that the competition in dual-task performance (in the case of the MDM, chairing 
whilst contributing to case reviews) is detrimental to one or both tasks that are being undertaken 
simultaneously [18], while evidence from patient safety and functional perspective shows that 
communication between healthcare professionals can be negatively affected by a steep authority 
gradient, which can emerge when a senior clinician chairs a MDM [15,19-22]. The latter finding is 
further supported by early social science research [23-24], the results of which were subsequently used 
to improve team effectiveness in many industries, including aviation [25].  
Objectives 
Our primary objectives were to 1) examine the underlying structure of team decision-making during 
case reviews, investigating how the different elements of the decision process cluster together, and 2) 
understand how it affects team outcome, i.e., the team ability to reach a treatment decision/plan.  
 
To achieve this, we conducted a series of analyses on a large multi-tumor database that was compiled 
using a novel validated instrument for the observational assessment of decision-making in cancer 
MDMs - namely, Metric for the Observation of Decision-Making in cancer MDTs, also known as, 
MDT-MODe [4]. Although tools have been developed to evaluate various aspects of MDM 
performance, to our knowledge, this is the only instrument designed specifically to measure the 
process of multidisciplinary decision-making.  
Methods 
Study Design 
This is a cross-sectional observational study that represents a secondary analysis of the data. 
Originally, the data were acquired through our centre’s ongoing research program in evaluating and 
improving MDT working across different tumors and was used to descriptively assess decision-
making process within cancer teams using MDT-MODe. Since this was a secondary analysis, ethical 
approval was not required, however at the time of data collection ethical approvals were in place for 
all prospective evaluations.  
Setting 
The study recruited four independent cancer teams between 2010 and 2014 from one teaching 
university hospital (lung cancer team) and three large community hospitals (breast, colorectal and 
urology cancer teams) of the London (UK) metropolitan area. Observations were conducted in real-
time over 10 consecutive meetings within each MDT by four trained surgeon evaluators (breast=SA, 
colorectal=SMS, lung=SS, urological=BWL) who assessed the cancer team that corresponded to their 
clinical specialty. Reliability was assessed by having four surgeon evaluators score a subset of cases in 
pairs. The evaluators were not members of the MDT they were assessing.  
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Participants and Study Size 
Participants were 4 multidisciplinary cancer teams with a total of 52 members, and an overall of 1,045 
individual case reviews discussed over a period of 10 weekly meetings respectively. Eligibility criteria 
for the study were defined as multidisciplinary cancer teams from the UK National Health Service 
(NHS) that represent four most common types of cancer (breast, lung urological and colorectal) and 
discuss patients referred to them for care planning recommendations. An availability sampling 
approach was used to identify teams that met eligibility criteria, while a set number of meetings within 
each team determined the number of case discussions for analysis.  
Variables and Measurements  
Case reviews within each meeting and across all four cancer teams were assessed in the same manner 
by assessors who were clinicians specialised in the cancer they observed, and trained beforehand in 
the use of the MDT-MODe, a quantitative observational assessment tool (Figure 1) [4]. Training in the 
use of the tool is essential in order to be able to use it – this is a general principle for instruments 
assessing human factors in clinical environments, such that the evaluations produced have a degree of 
accuracy and can be meaningfully used [29]. The tool has been validated, and previously used to 
assess various cancer MDTs [e.g. 26-28]. The instrument allows a trained evaluator (using the form 
shown in Figure 1) to provide for each case review carried out by the MDT a standardized score on a 
1-5 behaviorally anchored scale of the following variables in real-time: 
(i) Quality of information presented at the MDM as measured by six variables, namely, 
patient history, radiology results, pathology results, patient psychosocial aspects (i.e. 
psychological and social factors, including mental health difficulties, socio-economic issues, 
and personal circumstances), comorbidity (i.e., past medical history and performance status), 
and patients’ wishes or opinions regarding treatment. 
(ii) Quality of multidisciplinary case review as measured by the contributions of seven core 
disciplines, namely, chairperson, surgeon, oncologist, nurse, radiologist, histopathologist and 
coordinator. Quality of MDT chairing is evaluated based on national guidelines for England 
[13], which outline the core competencies that are important for chairing: meeting 
management, listening and communication, interpersonal relations, managing disruptive 
personalities and conflict, negotiations, facilitating effective consensual decision-making and 
time management. Other MDT-members are rated on the basis of their clear contribution of 
their specialty to the case review.  
The outcome measure is a dichotomous variable (yes/no) that allows recording whether or not a clear 
treatment decision was reached for a patient (Figure 1). In the statistical analysis, type of tumor was 
considered as a potential confounder. No other variables were included in the final model.  
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----------------------- 
Figure 1 
---------------------- 
Bias 
Efforts were made to address potential biases in the study. We addressed observer bias and had 
ensured reliability of evaluations on the MDT-MODe by having a subset of cases scored by the four 
clinical evaluators in pairs who were all trained and experienced in the use of the instrument. During 
data collection, each evaluator was blind to the other evaluators’ observations. All data were collated 
for analysis by a separate researcher (TS). We are aware that Hawthorne effect, i.e., teams changing 
their usual behavior due to being observed, is a natural limitation to observational studies, and in our 
study MDT members were aware that they were being observed. In England, MDMs are commonly 
attended by visiting clinicians, students, researchers, clinical auditors as well as interns and residents 
on rotation. This means that in practice being ‘observed’ in some way or other is rather common 
within these teams – and hence the presence of our study’s clinical observers would not be 
overwhelming to the teams. We therefore believe that the presence of the observer, discreetly 
positioned at the back of the MDT meeting, would have had minimal impact on the proceedings of the 
meetings, particularly as the study occurred over a number of weeks (and thus allowed for 
acclimatization of the teams to the observers), and the evaluators were clinicians (specialized in the 
cancer that they observed), the presence of whom within the MDT is natural. We return to the 
Hawthorne effect issue in the discussion.   
Statistical Methods 
Intra-class coefficient (ICC) analysis was initially used to assess reliability of evaluations. ICCs can 
range between 0 and 1, with higher values indicating better agreement between evaluators. A recent 
expert consensus has defined a reliability coefficient of 0.70 as a minimum value for data to be used 
for research purposes [29].  
Exploratory factor analysis (EFA) and logistic regression were subsequently carried out to assess the 
underlying structure of decision-making process during case reviews. The variables that were included 
in the EFA were individual items of information and specialist contribution quality as assessed by 
MDT-MODe. EFA extracted factors (using a regression method) were then entered in a multiple 
logistic regression model as predictor variables to assess their relation to the outcome, i.e., team ability 
to reach a decision with 0 denoting no decision reached, and 1 decision reached. Variable representing 
individual teams within the sample (i.e., breast, lung, urology and colorectal cancer teams) was also 
entered in the regression model as a covariate to examine its’ potential confounding effect. 
Significance was set at p < 0.05. 
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All analyses were carried out using SPSS® version 20.0 software, and there were no missing data.  
Results 
Descriptive Analysis 
The descriptive data for meeting characteristics are shown in Table 1. Representing the most common 
cancers in the UK, the sample consisted of overall 1,045 case discussions across 4 teams within a NHS 
setting. The composition of health care personnel in MDTs did not significantly vary across groups. 
All teams consisted of a coordinator (administrator), chair and senior (Consultant/Attending level) 
cancer specialists, i.e., surgeons, oncologists, radiologists, pathologists, and cancer nurses, with the 
exception of lung, where a chest physician was also present. Table 2 shows detailed descriptive data 
for the MDT-MODe variables across all four cancer teams. 
------------------------------ 
Tables 1 & 2 
------------------------------ 
Reliability of Evaluations: Intra-class correlation coefficients (ICCs)     
Inter-evaluator agreement was assessed via ICCs on a randomly selected subset of the observed cases 
(N=273, 26% of the total cohort). High reliability was obtained across all tumors; breast: median 
ICC=0.92 (range 0.27-1.00); colorectal: median ICC=0.83 (range 0.69-0.96); lung: median ICC=0.86 
(range 0.71-0.99); and urological: median ICC=0.71 (range 0.31-0.87). This finding means that all 
four surgeon evaluators were consistent in their use of the MDT-MODe instrument across evaluated 
cases. The full intrarater reliability matrix for all individual items across all four cancer teams is 
provided as the Supplementary data table. 
Anatomy of Decision-Making: Exploratory Factor Analysis (EFA) 
To assess the underlying structure of the decision-making process in MDM, an EFA was applied to the 
13 MDT-MODe items. All the criteria for factor analysis were met – sample size was adequate (KMO 
= 0.67), and the variables sufficiently intercorrelated, (𝑋2(78) = 3329.18, p < 0.001), with none of the 
coefficients being particularly large or zero. Based on (i) Kaiser’s criterion (eigenvalues for the first 
six factors were 2.99, 2.11, 1.34, 1.19, 0.95, 0.89), (ii) Scree plot and (iii) clinical considerations, 4 
factors were extracted and rotated to simple structure via the oblique Promax algorithm with the 
Kappa parameter set to 4. Oblique rotation was chosen because it is considered a more accurate, 
reproducible solution, allowing the factors to correlate [30]. The four factors together explained 59% 
of the variance in the 13 MDT-MODe items. All items were well represented in the extracted four 
factors, with an average communality of 0.59. The best represented items were radiologists’ input, ℎ2 
= 0.84, pathologists’ input, ℎ2 = 0.83, radiological information, ℎ2 = 0.83, and pathological 
information, ℎ2 = 0.84, while the least well represented item was chair’s input ℎ2 = 0.39. 
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Table 3 presents the resulting factor pattern matrix. The highest-loading variables on the first factor 
were patient views on the treatment options (0.70), oncologists’ input into case discussion (0.67), 
nurses’ input into case discussion (0.65), and patient psychosocial aspects (0.60).  Accordingly, this 
factor was labelled ‘Holistic and Clinical inputs’, representing patients’ holistic and clinical needs. 
The highest-loading variables on the second factor were patient radiological information presented to 
the team (0.91) and radiologists’ input into case discussion (0.93).  Accordingly, this factor was 
labelled ‘Radiology’, representing radiological profile of patients’ disease. The highest-loading 
variables on the third factor were patient pathological information presented to the team (0.90) and 
pathologists’ input into case discussion (0.96). Accordingly, this factor was labelled ‘Pathology’, 
representing pathological profile of patients’ disease. The highest-loading variables on the fourth 
factor were coordinator’s (0.68) and meeting chair’s (0.61) inputs into case discussion. Accordingly, 
this factor was labelled ‘Meeting Management’, representing the management of case discussions 
within the meeting (chair), and general management and organisation of cases for discussion 
(coordinator). Figure 2 shows a graphical representation of the four-factor model. 
 
.------------------------------ 
Table 3 & Figure 2 
------------------------------ 
As evident from Table 3, one variable, namely, surgeons’ input, cross-loads positively (0.43) on 
‘Holistic and Clinical inputs’, and negatively (-0.41) on ‘Meeting Management’. Since surgeons in our 
sample also chaired the meetings, thus undertaking two tasks simultaneously, we further explored the 
relationship between the two using Spearman correlational analysis. A significant negative association 
was found between surgeons’ and chairs’ inputs to case reviews (r = -0.19, p < 0.01), indicating that as 
the surgeons’ inputs increased, the chairs’ inputs decreased. In contrast, the relationship between 
surgeons’ and coordinators’ inputs was non-significant (r = -0.04, p > 0.05). It is reasonable to 
conclude, therefore, that the negative cross-loading in the EFA is driven by the negative surgeon-chair 
association. This finding is in line with the theory of dual task interference [18], as discussed later. 
Factor inter-correlations were generally low at r = 0.26 or less. The full factor inter-correlation matrix 
is available upon request from the corresponding author. 
Predictors of Outcome: Logistic Regression 
To explore the relation between the four factors and the outcome variable, namely, the team ability to 
reach a treatment decision on first case review, we performed a multiple logistic regression analysis. 
After adjusting for tumor type, all four factors, including ‘Holistic and Clinical inputs’ (Wald(1) = 
17.88, p  < 0.001), ‘Radiology’ (Wald(1) = 12.01, p < 0.001), ‘Pathology’ (Wald(1) = 23.22, p  < 
0.001), and ‘Meeting Management’ (Wald(1) = 12.30, p < 0.001) were significantly related to the 
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treatment decision. To facilitate interpretation, we converted the odds ratios into probability 
percentages, using the following formula: odds/(odds+1) x 100 = probability % [31]. We found that 
‘Holistic and Clinical’ inputs, ‘Radiology’ and ‘Pathology’ contributed the most to the probability of 
the team to reach a treatment decision for a patient (see Table 4).  
----------------------------- 
Table 4  
------------------------------ 
Discussion  
Summary 
The current study used multivariate statistical methods to gain a better understanding of the anatomy 
of group decision-making in cancer MDMs, and how it relates to team ability to reach treatment 
recommendation. We showed that the decision-making process in cancer MDMs is driven by four 
underlying factors – namely, ‘Holistic and Clinical inputs’, ‘Pathology’, ‘Radiology’, and ‘Meeting 
Management’. These were all significantly predictive of team ability to reach a treatment decision on 
first case review. The inputs of chairs (who were surgeons in our sample) were shown to compete with 
their corresponding disciplinary contributions to case reviews at the detriment of the meeting 
management – i.e., as surgeons’ input to case reviews increased, chair’s input decreased.  
Limitations  
We have used observational data with participants being aware that they were being evaluated, hence 
we cannot rule out observer biases and the Hawthorne effect. This is a natural limitation to all 
observational evaluations, and in our dataset, we used blinded clinical evaluators (the presence of 
whom within a MDT is natural) and a previously validated tool, ensuring satisfactory inter-assessor 
reliability. Further, the nature of MDT-MODe may not do justice to the complex roles of the MDT 
chairperson and coordinator. This is being addressed via a more detailed evaluation scale we are 
currently constructing for chairing skills [33]. Although we have made an attempt to control for the 
confounding effects of tumor type, we acknowledge that our data are derived from different 
institutions and MDTs, and that team culture including different values, beliefs and attitudes could 
influence outcomes [16]. This may have affected institutional versus team-specific or tumor-specific 
factors impacting on team decision-making. In a similar vein, conscious or unconscious preferences 
for treatment may be embedded into individual specialists’ decision-making; ideally, these should also 
be factored into the decision-making ‘model’ of the MDM as they are likely to be a stable feature of 
each individual physician’s decision style. Our study was not designed to address all of these 
complexities, which would have rendered its scope unfeasible. Future work should therefore explore a 
large stratified sample of cases across hospitals and tumors to further validate our findings, and also 
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the intra-individual physician preferences for treatment options. Such research would offer further 
understanding of how these differences affect multidisciplinary decision-making process.  
Overall Interpretation 
Previous research has shown that clinical decision-making process is an essential part of effective 
MDT working [13]. Our findings build on this by showing that the decision-making process in MDMs 
is driven by four underlying factors representing all core disciplines and the complete patient profile - 
both essential for the teams’ ability to reach a decision. In a recent study, MDT members reported the 
importance of member attendance, availability of patient information, considerations of patient 
comorbidities, patient choices and their current state of health for decision-making [9]. Our paper 
corroborates this finding by showing that in order for the team to be able to reach a treatment 
recommendation on first case review, all participating disciplines and the complete patient profile are 
necessary. This is also in line with the functional perspective of group decision-making, which links 
the diversity of groups with better performance and range of abilities, although at the expense of 
effective processes and equality of participation [15] – a pattern previously observed in MDMs [4-6]. 
Quality improvement efforts, therefore, could consider focusing on the factors identified by our study, 
and assessing them against team processes (e.g. social loafing, blocking, shared information bias), 
quality of decisions made, and patient satisfaction. 
Moreover, our finding of negative surgeon-chair’s input association whereby the surgeons’ inputs into 
case review increase as the chairs’ inputs decrease, is in line with the theory of dual task interference, 
which shows that the competition in dual-task performance is at the detriment of one or both tasks 
[18]. In our sample, chairing was led by the surgical specialty that is also required to provide input 
into case reviews; these are both demanding cognitive tasks. Our study shows that providing both 
types of input at the same time appears to be at the expense of the coordination of the meeting. More 
specifically, when surgical input into case reviews increases, the chair’s input decreases. This is an 
important finding because such internal factors emanating from within the group can affect the way 
the team performs [15]. What is more, this finding can spur strategies for improving MDM practice. 
For instance, assigning a chairing role to a clinically non-contributing individual (e.g. MDT leads from 
other specialties, or cancer managers), trained in team management skills may allow the contributing 
members to focus solely on case reviews and clinical decision-making. Alternatively, rotating the 
chairing duty during a MDM could allow different team members to chair when their direct input is 
not required. Also, experienced specialist nurses could potentially take on this role [32]. 
Further Research  
One question that was directly raised by our findings relates to chairing and dual-task interference. 
Studies should look specifically into the impact of having one of the contributing disciplines in the 
MDT chair the meeting, and test alternative options for meeting leadership that address the burden of 
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the chairing task to the clinical decision making. A second question for future research to address 
relates to the effects of authority gradients on team decision-making process. Authority gradients were 
first defined in aviation where it was observed that differences in seniority and authority impede 
effective communication between pilots and co-pilots [22], and the concept was subsequently 
introduced to medicine in the Institute of Medicine Report, To Err Is Human [21]. While dual-task 
interference is a valid and tested theory that should be investigated further within MDMs, one cannot 
ignore that meetings are attended by more than one person from each specialty. This begs the question 
as to what is the effect of the chair’s authority gradient on information exchange and contributions to 
case reviews from other members of the chair’s discipline. Additionally, this effect should also be 
explored in relation to the other disciplines within the team since nurses, for example, have 
traditionally lower team status. The negative impact of authority gradients on communication between 
healthcare professionals and on patient safety has been well-documented [15,19-22], and classic social 
science research had showed the detrimental effects of blind obedience that such gradients can create 
[23-24]. To illustrate, in a recent interview with MDT members regarding the effectiveness of their 
meetings, one doctor reported: “I am always amazed how very able staff can be so passive” [14]. 
Having an effectively trained leader, and respectful team climate that balance out the authority 
gradients and encourages inputs from all contributing members and disciplines may help improve the 
decision-making process and guard against potential team biases. 
Generalizability 
Although this is a large-scale study for its nature (based on in vivo observations), generalizability of 
our findings may be limited to the most common cancer MDTs within the NHS. Replication and 
assessment of the generalizability of the current findings to other cancer MDTs, in particular the 
lower-frequency cancers, needs to be examined to determine the extent of which they apply to them.  
Conclusion 
As our results demonstrate for the first time, MDT decisions in most common cancers are driven by 
four underlying factors encompassing all participating disciplines and a complete patient profile. It 
seems that all of these elements are necessary for the collective decision-making ability of a team. We 
also demonstrated a negative relationship between chairs’ inputs and their corresponding disciplinary 
clinical input, possibly indicating dual-task interference. Further research could profitably investigate 
how chairing and authority gradients affect team interactions and contributions to case review in 
MDMs with a view to improving service quality and group decision-making in a natural context. 
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Figure 1 Metric for the observation of decision-making used to assess case discussions in cancer 
multidisciplinary team meetings [4] 
Figure 2 Diagram depicting the underlying components of decision-making processes in cancer 
multidisciplinary team meetings 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
